Substance / Medication

Reviparin

Overview

Active Ingredient
reviparin
RxNorm CUI
75960

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients.
Massicotte Patricia, Julian Jim A, Marzinotto Velma et al. · Thromb Res · 2003
PMID: 12706637Trial
Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization.
Lassen Michael R, Borris Lars C, Nakov Roumen L · N Engl J Med · 2002
PMID: 12213943Trial
Dose effect relationship of reviparin in chronic hemodialysis: a crossover study versus nadroparin.
Reach I, Luong N, Chastang C et al. · Artif Organs · 2001
PMID: 11493282Trial
Interaction between the LMWH reviparin and aspirin in healthy volunteers.
Klinkhardt U, Breddin H K, Esslinger H U et al. · Br J Clin Pharmacol · 2000
PMID: 10759689TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Reviparin (substance)
SNOMED CT
395998002
UMLS CUI
C0254215
RxNorm CUI
75960

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.